APAna Lúcia de Matos Paz

Ana Lúcia de Matos Paz

*This is an algorithmically generated author record based on publicly available information.

Research Interests


Ana Lúcia de Matos Paz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Principais aspectos da cirurgia bucomaxilofacial no paciente sob terapia com bisfosfonatos

    by Rafael Meneses Bomfim, Wanessa Maurício da Silva, Kimberly Damazio Tiburcio, Jamesson dos Santos Celestino, Ana Letícia de Albuquerque Oliveira, Yanca dos Santos, Talita Gomes Diniz, Rhuan Alexandre Pereira da Silva, Ana Lúcia de Matos Paz, Davi Torquato Dantas

    Bisphosphonates are a class of compounds used to treat many different medical conditions. Its use has increased dramatically in recent years as new indications for its use have emerged. Current indications include the treatment of multiple myeloma, hypercalcemia, osteolytic lesions of metastatic disease, Paget's disease, and, most commonly, osteoporosis. While these drugs are beneficial, a significant and potentially devastating complication - osteonecrosis of the jaws - has been reported termed bisphosphonate-related osteonecrosis (BRON), and has been increasingly recognized. In this context, this study aims to carry out a literature review regarding the main aspects of oral and maxillofacial surgery in patients undergoing therapy with bisphosphonates, and to report the clinical manifestations of mandibular osteonecrosis related to the drug in question. In order to achieve this objective, a bibliographical survey was carried out in the databases SciVerse Scopus, Scientific Electronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) and ScienceDirect. The results indicate that, with the increasing use of bisphosphonates in the female population, BRON of the mandible is likely to be an increasing problem that will require complex treatment and management by oral and maxillofacial surgeons. As such, our expertise will be critical in providing answers to difficult questions of management and treatment outcomes. Unfortunately, at this time, only palliative care can be offered to patients suffering from this potentially devastating process. Increased awareness and vigilance can reduce potential complications. More studies looking at specific risk factors may help prevent this process before it starts.